{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T11:37:51Z","timestamp":1783510671078,"version":"3.55.0"},"reference-count":39,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,1,25]],"date-time":"2018-01-25T00:00:00Z","timestamp":1516838400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002241","name":"Japan Science and Technology Agency","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002241","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009029","name":"Adaptable and Seamless Technology Transfer Program through Target-Driven R and D","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009029","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009029","name":"Adaptable and Seamless Technology Transfer Program through Target-Driven R and D","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009029","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Immunobiology"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1016\/j.imbio.2017.10.040","type":"journal-article","created":{"date-parts":[[2017,10,18]],"date-time":"2017-10-18T16:17:59Z","timestamp":1508343479000},"page":"319-326","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Human monoclonal antibodies neutralizing influenza virus A\/H1N1pdm09 and seasonal A\/H1N1 strains \u2013 Distinct Ig gene repertoires with a similar action mechanism"],"prefix":"10.1016","volume":"223","author":[{"given":"Satoshi","family":"Hiroi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Motoki","family":"Kuhara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiro","family":"Kishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken-ichiro","family":"Ono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shun","family":"Matsuzawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naomasa","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Komano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.imbio.2017.10.040_bib0005","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1086\/595861","article-title":"Marshfield Influenza Study G. Effectiveness of inactivated influenza vaccines varied substantially with antigenic match from the 2004\u20132005 season to the 2006\u20132007 season","volume":"199","author":"Belongia","year":"2009","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.imbio.2017.10.040_bib0010","doi-asserted-by":"crossref","first-page":"6743","DOI":"10.1128\/JVI.03562-13","article-title":"A broadly neutralizing human monoclonal antibody directed against a novel conserved epitope on the influenza virus H3 hemagglutinin globular head","volume":"88","author":"Benjamin","year":"2014","journal-title":"J. Virol."},{"key":"10.1016\/j.imbio.2017.10.040_bib0015","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/j.bbrc.2014.09.008","article-title":"A human monoclonal antibody derived from a vaccinated volunteer recognizes heterosubtypically a novel epitope on the hemagglutinin globular head of H1 and H9 influenza A viruses","volume":"452","author":"Boonsathorn","year":"2014","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.imbio.2017.10.040_bib0020","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.virol.2009.12.014","article-title":"Monoclonal antibodies isolated from human B cells neutralize a broad range of H1 subtype influenza A viruses including swine-origin Influenza virus (S-OIV)","volume":"399","author":"Burioni","year":"2010","journal-title":"Virology"},{"key":"10.1016\/j.imbio.2017.10.040_bib0025","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1126\/science.1225416","article-title":"Broadly neutralizing antibodies present new prospects to counter highly antigenically diverse viruses","volume":"337","author":"Burton","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.imbio.2017.10.040_bib0030","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1146\/annurev-immunol-032712-095916","article-title":"Broadly neutralizing antiviral antibodies","volume":"31","author":"Corti","year":"2013","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.imbio.2017.10.040_bib0035","first-page":"2","article-title":"Efficient methods to isolate human monoclonal antibodies from memory B cells and plasma cells","author":"Corti","year":"2014","journal-title":"Microbiol. Spectr."},{"key":"10.1016\/j.imbio.2017.10.040_bib0040","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1126\/science.1205669","article-title":"A neutralizing antibody selected from plasma cells that binds to group 1 and group 2 influenza A hemagglutinins","volume":"333","author":"Corti","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.imbio.2017.10.040_bib0045","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.coi.2015.06.014","article-title":"Engineering humoral immunity as prophylaxis or therapy","volume":"35","author":"Deal","year":"2015","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.imbio.2017.10.040_bib0050","doi-asserted-by":"crossref","first-page":"7149","DOI":"10.1128\/JVI.02975-12","article-title":"Structure of a classical broadly neutralizing stem antibody in complex with a pandemic H2 influenza virus hemagglutinin","volume":"87","author":"Dreyfus","year":"2013","journal-title":"J. Virol."},{"key":"10.1016\/j.imbio.2017.10.040_bib0055","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.bbrc.2010.05.161","article-title":"Development of a safe and convenient neutralization assay for rapid screening of influenza HA-specific neutralizing monoclonal antibodies","volume":"397","author":"Du","year":"2010","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.imbio.2017.10.040_bib0060","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1128\/JVI.02344-12","article-title":"Identification and structural characterization of a broadly neutralizing antibody targeting a novel conserved epitope on the influenza virus H5N1 hemagglutinin","volume":"87","author":"Du","year":"2013","journal-title":"J. Virol."},{"key":"10.1016\/j.imbio.2017.10.040_bib0065","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1038\/nature11414","article-title":"Cross-neutralization of influenza A viruses mediated by a single antibody loop","volume":"489","author":"Ekiert","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.imbio.2017.10.040_bib0070","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1056\/NEJMoa0906453","article-title":"Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus","volume":"361","author":"Hancock","year":"2009","journal-title":"New Engl. J. Med."},{"key":"10.1016\/j.imbio.2017.10.040_bib0075","doi-asserted-by":"crossref","first-page":"414637","DOI":"10.1155\/2015\/414637","article-title":"Prospects of HA-based universal influenza vaccine","volume":"2015","author":"Hashem","year":"2015","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.imbio.2017.10.040_bib0080","first-page":"1","article-title":"Strategies towards universal pandemic influenza vaccines","author":"He","year":"2015","journal-title":"Expert Rev. Vaccines"},{"key":"10.1016\/j.imbio.2017.10.040_bib0085","doi-asserted-by":"crossref","first-page":"7130","DOI":"10.1128\/JVI.00420-14","article-title":"Conserved neutralizing epitope at globular head of hemagglutinin in H3N2 influenza viruses","volume":"88","author":"Iba","year":"2014","journal-title":"J. Virol."},{"key":"10.1016\/j.imbio.2017.10.040_bib0090","doi-asserted-by":"crossref","first-page":"e8553","DOI":"10.1371\/journal.pone.0008553","article-title":"Predicting the antigenic structure of the pandemic (H1N1) 2009 influenza virus hemagglutinin","volume":"5","author":"Igarashi","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.imbio.2017.10.040_bib0095","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1126\/science.aac7263","article-title":"A stable trimeric influenza hemagglutinin stem as a broadly protective immunogen","volume":"349","author":"Impagliazzo","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.imbio.2017.10.040_bib0100","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1038\/nm.1966","article-title":"A rapid and efficient single-cell manipulation method for screening antigen-specific antibody-secreting cells from human peripheral blood","volume":"15","author":"Jin","year":"2009","journal-title":"Nat. Med."},{"key":"10.1016\/j.imbio.2017.10.040_bib0105","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1086\/648378","article-title":"Pre- and postexposure use of human monoclonal antibody against H5N1 and H1N1 influenza virus in mice: viable alternative to oseltamivir","volume":"200","author":"Koudstaal","year":"2009","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.imbio.2017.10.040_bib0110","doi-asserted-by":"crossref","first-page":"10905","DOI":"10.1128\/JVI.00700-11","article-title":"A broadly neutralizing human monoclonal antibody that recognizes a conserved, novel epitope on the globular head of the influenza H1N1 virus hemagglutinin","volume":"85","author":"Krause","year":"2011","journal-title":"J. Virol."},{"key":"10.1016\/j.imbio.2017.10.040_bib0115","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.bbrc.2009.06.151","article-title":"Broad neutralizing human monoclonal antibodies against influenza virus from vaccinated healthy donors","volume":"387","author":"Kubota-Koketsu","year":"2009","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.imbio.2017.10.040_bib0120","doi-asserted-by":"crossref","first-page":"9047","DOI":"10.1073\/pnas.1118979109","article-title":"Pandemic H1N1 influenza vaccine induces a recall response in humans that favors broadly cross-reactive memory B cells","volume":"109","author":"Li","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.imbio.2017.10.040_bib0125","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.jviromet.2009.02.014","article-title":"High-throughput isolation of immunoglobulin genes from single human B cells and expression as monoclonal antibodies","volume":"158","author":"Liao","year":"2009","journal-title":"J. Virol. Methods"},{"key":"10.1016\/j.imbio.2017.10.040_bib0130","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.chom.2013.06.004","article-title":"An in vivo human-plasmablast enrichment technique allows rapid identification of therapeutic influenza A antibodies","volume":"14","author":"Nakamura","year":"2013","journal-title":"Cell Host. Microb."},{"key":"10.1016\/j.imbio.2017.10.040_bib0135","doi-asserted-by":"crossref","first-page":"911","DOI":"10.3851\/IMP1413","article-title":"Prophylactic and therapeutic efficacy of a chimeric monoclonal antibody specific for H5 haemagglutinin against lethal H5N1 influenza","volume":"14","author":"Prabhu","year":"2009","journal-title":"Antiviral Ther."},{"key":"10.1016\/j.imbio.2017.10.040_bib0140","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.antiviral.2010.09.007","article-title":"A cross-reactive neutralizing monoclonal antibody protects mice from H5N1 and pandemic (H1N1) 2009 virus infection","volume":"88","author":"Sakabe","year":"2010","journal-title":"Antiviral Res."},{"key":"10.1016\/j.imbio.2017.10.040_bib0145","doi-asserted-by":"crossref","first-page":"315","DOI":"10.3389\/fimmu.2015.00315","article-title":"Antibody-based strategies to prevent and treat influenza","volume":"6","author":"Shriver","year":"2015","journal-title":"Front. Immunol."},{"key":"10.1016\/j.imbio.2017.10.040_bib0150","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/nsmb.1566","article-title":"Structural and functional bases for broad-spectrum neutralization of avian and human influenza A viruses","volume":"16","author":"Sui","year":"2009","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.imbio.2017.10.040_bib0155","doi-asserted-by":"crossref","first-page":"e3942","DOI":"10.1371\/journal.pone.0003942","article-title":"Heterosubtypic neutralizing monoclonal antibodies cross-protective against H5N1 and H1N1 recovered from human IgM+ memory B cells","volume":"3","author":"Throsby","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.imbio.2017.10.040_bib0160","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1586\/14760584.5.2.261","article-title":"Prevention and treatment of respiratory syncytial virus infection in infants: an update","volume":"5","author":"Venkatesh","year":"2006","journal-title":"Expert Rev. Vaccines"},{"key":"10.1016\/j.imbio.2017.10.040_bib0165","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/296115a0","article-title":"Molecular mechanisms of variation in influenza viruses","volume":"296","author":"Webster","year":"1982","journal-title":"Nature"},{"key":"10.1016\/j.imbio.2017.10.040_bib0170","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1084\/jem.20101352","article-title":"Broadly cross-reactive antibodies dominate the human B cell response against 2009 pandemic H1N1 influenza virus infection","volume":"208","author":"Wrammert","year":"2011","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.imbio.2017.10.040_bib0175","first-page":"103","article-title":"Immunoprophylaxis of RSV infection: advancing from RSV-IGIV to palivizumab and motavizumab","volume":"317","author":"Wu","year":"2008","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"10.1016\/j.imbio.2017.10.040_bib0180","doi-asserted-by":"crossref","first-page":"e77892","DOI":"10.1371\/journal.pone.0077892","article-title":"Emerging antigenic variants at the antigenic site Sb in pandemic A(H1N1)2009 influenza virus in Japan detected by a human monoclonal antibody","volume":"8","author":"Yasugi","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.imbio.2017.10.040_bib0185","doi-asserted-by":"crossref","first-page":"e1003150","DOI":"10.1371\/journal.ppat.1003150","article-title":"Human monoclonal antibodies broadly neutralizing against influenza B virus","volume":"9","author":"Yasugi","year":"2013","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.imbio.2017.10.040_bib0190","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1038\/nature07231","article-title":"Neutralizing antibodies derived from the B cells of 1918 influenza pandemic survivors","volume":"455","author":"Yu","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.imbio.2017.10.040_bib0195","doi-asserted-by":"crossref","first-page":"4549","DOI":"10.1128\/JVI.00078-15","article-title":"An anti-H5N1 influenza virus FcDART antibody is a highly efficacious therapeutic agent and prophylactic against H5N1 influenza virus infection","volume":"89","author":"Zanin","year":"2015","journal-title":"J. Virol."}],"container-title":["Immunobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S017129851730181X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S017129851730181X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T16:43:33Z","timestamp":1759250613000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S017129851730181X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":39,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,3]]}},"alternative-id":["S017129851730181X"],"URL":"https:\/\/doi.org\/10.1016\/j.imbio.2017.10.040","relation":{},"ISSN":["0171-2985"],"issn-type":[{"value":"0171-2985","type":"print"}],"subject":[],"published":{"date-parts":[[2018,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Human monoclonal antibodies neutralizing influenza virus A\/H1N1pdm09 and seasonal A\/H1N1 strains \u2013 Distinct Ig gene repertoires with a similar action mechanism","name":"articletitle","label":"Article Title"},{"value":"Immunobiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.imbio.2017.10.040","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Authors. Published by Elsevier GmbH.","name":"copyright","label":"Copyright"}]}}